About Cubist
Products & Pipeline
Investor Relations
Careers
News & Media
Products
CUBICIN
®
(daptomycin for injection)
Pipeline
Gram-Negative Bacterial Infections
CXA-201
CB-182,804
Clostridium Difficile
-Associated Diarrhea
Pre-Clinical and Discovery
Respiratory Syncytial Virus
Gram-negative
CXA-201
**
CDAD
CB-183,315
Gram-negative
CB-182,804
**
Rights under a license from Astellas Pharma Inc. acquired with Cubist's acquisition of Calixa Therapeutics Inc.